Also known as: S&P Global
S&P Global is a U.S. publicly traded financial information and analytics company headquartered in New York City. Founded in 1917, it operates major businesses in ratings, market intelligence, indices, energy data, and mobility.
Johnson & Johnson said revenue could reach about $100.5 billion at the midpoint in 2026 after 2024 net sales rose 6% to $94.2 billion. The company faces talc litigation, Stelara patent losses and U.S. drug price negotiations.
Lupin Limited reported strong Q3 FY26 results with total sales of ₹71,005 million, up 26% year-over-year, and received US FDA approval for its pegfilgrastim biosimilar Armlupeg™, which has not yet been launched.
